Cargando…
Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells
Tamoxifen is still the most commonly used endocrine therapy drug for estrogen receptor (ER)-positive breast cancer patients and has an excellent outcome, but tamoxifen resistance remains a great impediment to successful treatment. Recent studies have prompted an anti-tumor effect of aspirin. Here, w...
Autores principales: | Cheng, Ran, Liu, Ya-Jing, Cui, Jun-Wei, Yang, Man, Liu, Xiao-Ling, Li, Peng, Wang, Zhan, Zhu, Li-Zhang, Lu, Si-Yi, Zou, Li, Wu, Xiao-Qin, Li, Yu-Xia, Zhou, You, Fang, Zheng-Yu, Wei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444740/ https://www.ncbi.nlm.nih.gov/pubmed/28415819 http://dx.doi.org/10.18632/oncotarget.16325 |
Ejemplares similares
-
USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1
por: Li, Gen, et al.
Publicado: (2021) -
CyclinD1 protein expressed in pterygia is associated with β-catenin protein localization
por: Tung, Jai-Nien, et al.
Publicado: (2010) -
Estrogen Receptor Beta (ERβ) Mediated-CyclinD1 Degradation via Autophagy Plays an Anti-Proliferation Role in Colon Cells
por: Wei, Yong, et al.
Publicado: (2019) -
CyclinD1 and p57(kip2) as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma
por: Ru, Yi, et al.
Publicado: (2017) -
CyclinD1, a prominent prognostic marker for endometrial diseases
por: Liang, Shuo, et al.
Publicado: (2013)